PETALING JAYA, April 9 -- For many people living with cancer, financial hardship is a struggle that is all too familiar.

A study by the Asean Costs in Oncology (Action) showed that over 75 per cent of cancer patients in Southeast Asia experience death or financial catastrophe just one year after getting diagnosed.

In light of this statistic, Nilai Medical Centre (Nilai Medical) in Negri Sembilan has partnered with Roche Malaysia to launch the NMCares Targeted Therapy Welfare Programme to provide financial aid to HER2-positive breast cancer patients.

The programme will be carried out via Roche Cares, a tripartite co-payment model which allows patients to access targeted therapy at a subsidised cost, making it possible for eligible patie...